@WHO: @DrTedros @AfricaCDC "This selection will be based on how advanced the technology is, in terms of clinical efficacy data, and on the terms under which the company is willing to share its technology"-@DrTedros #VaccinEquity https://t.co/qJ4iZjZh4o

http://twitter.com/WHO
via IFTTT